Albuminuria can develop rapidly within the first few years after the onset of type 2 diabetes
Read More »Issue 108 Item 13 Congress to Vote on Legislation to Fight Obesity with 80 Milli
Obesity reaches “epidemic proportion,” leading to 300,000 premature deaths and costing the economy $120 billion annually.
Read More »Issue 109 Item 14 Microvascular Processes Plays A Role in Development of Diabete
Microvascular damage may play a role in the initial development of diabetes.
Read More »ADA: A ‘Breakthrough’ for Diabetic Peripheral Neuropathy
LY333531, is the first drug to attack the cause of nerve-damaging diabetic peripheral neuropathy.
Read More »Issue 111 Item 19 INGAP Peptide – An Initiator of Beta Cell Growth
You will be hearing more about INGAP in upcoming newsletters Recent studies have shown that induction of islet neogenesis from adult pancreatic stem cells has the potential for restoring beta cell mass in diabetes.
Read More »Issue 111 Item 2 ADA: Good Glycemic Control Is Not Enough in Managing Diabetes
Priorities are misplaced because coronary artery disease is the major cause of death in patients with type 2 diabetes mellitus
Read More »Issue 107 Item 11 Advanced Glycation End Products (AGEs) Causes Endothelial Dysf
Study investigated whether changes in endothelium-dependent vasodilation, a marker of endothelial function, were related to serum AGEs concentrations in patients with type 2 diabetes.
Read More »Issue 108 Item 12 High Blood Pressure Treatment a ‘Must’ for Diabetes
Reduces stroke by 44% and reduces kidney and eye disease for patients with Type 2 diabetes
Read More »Issue 109 Item 13 Predictors of Acute Complications in Children With Type 1 Diab
Study determines the factors that predict the incidence of ketoacidosis and severe hypoglycemia in children. Diabetic ketoacidosis and severe hypoglycemia are acute complications of type 1 diabetes that are related, respectively, to insufficient or excessive insulin treatment. However, little is known about additional modifiable risk factors.
Read More »Issue 110 Item 13 ADA: Xenical (Orlistat) Helpful For Type 2 Diabetics With High
Orlistat (Xenical) has a beneficial effect on HbA1c levels, fasting plasma glucose and waist circumference in patients with baseline hemoglobin A1c (HbA1c) levels of 8 percent or greater.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.